Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors

被引:146
作者
Chintharlapalli, Sudhakar [2 ,3 ]
Papineni, Sabitha [2 ,4 ]
Lei, Ping [2 ]
Pathi, Satya [1 ]
Safe, Stephen [1 ]
机构
[1] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA
[2] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA
[3] Eli Lilly Co, Div Oncol, Indianapolis, IN USA
[4] Dow Agrosci, Indianapolis, IN USA
基金
美国国家卫生研究院;
关键词
DNA-MISMATCH-REPAIR; NF-KAPPA-B; PANCREATIC-CANCER; COLORECTAL-CANCER; FACTOR EXPRESSION; ONCOGENIC MICRORNA-27A; TOLFENAMIC ACID; GENE; RISK; CYCLOOXYGENASE-2;
D O I
10.1186/1471-2407-11-371
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Betulinic acid (BA) inhibits growth of several cancer cell lines and tumors and the effects of BA have been attributed to its mitochondriotoxicity and inhibition of multiple pro-oncogenic factors. Previous studies show that BA induces proteasome-dependent degradation of specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 in prostate cancer cells and this study focused on the mechanism of action of BA in colon cancer cells. Methods: The effects of BA on colon cancer cell proliferation and apoptosis and tumor growth in vivo were determined using standardized assays. The effects of BA on Sp proteins and Sp-regulated gene products were analyzed by western blots, and real time PCR was used to determine microRNA-27a (miR-27a) and ZBTB10 mRNA expression. Results: BA inhibited growth and induced apoptosis in RKO and SW480 colon cancer cells and inhibited tumor growth in athymic nude mice bearing RKO cells as xenograft. BA also decreased expression of Sp1, Sp3 and Sp4 transcription factors which are overexpressed in colon cancer cells and decreased levels of several Sp-regulated genes including survivin, vascular endothelial growth factor, p65 sub-unit of NF kappa B, epidermal growth factor receptor, cyclin D1, and pituitary tumor transforming gene-1. The mechanism of action of BA was dependent on cell context, since BA induced proteasome-dependent and proteasome-independent downregulation of Sp1, Sp3 and Sp4 in SW480 and RKO cells, respectively. In RKO cells, the mechanism of BA-induced repression of Sp1, Sp3 and Sp4 was due to induction of reactive oxygen species (ROS), ROS-mediated repression of microRNA-27a, and induction of the Sp repressor gene ZBTB10. Conclusions: These results suggest that the anticancer activity of BA in colon cancer cells is due, in part, to downregulation of Sp1, Sp3 and Sp4 transcription factors; however, the mechanism of this response is cell context-dependent.
引用
收藏
页数:12
相关论文
共 50 条
[1]  
Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO
[2]  
2-C
[3]   Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins [J].
Abdelrahim, M ;
Safe, S .
MOLECULAR PHARMACOLOGY, 2005, 68 (02) :317-329
[4]   Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells [J].
Abdelrahim, M ;
Smith, R ;
Burghardt, R ;
Safe, S .
CANCER RESEARCH, 2004, 64 (18) :6740-6749
[5]   Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells [J].
Abdelrahim, Maen ;
Baker, Cheryl H. ;
Abbruzzese, James L. ;
Sheikh-Hamad, David ;
Liu, Shengxi ;
Cho, Sung Dae ;
Yoon, Kyungsil ;
Safe, Stephen .
CANCER RESEARCH, 2007, 67 (07) :3286-3294
[6]   Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation [J].
Abdelrahim, Maen ;
Baker, Cheryl H. ;
Abbruzzese, James L. ;
Safe, Stephen .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (12) :855-868
[7]   YY1 and Sp1 transcription factors bind the human transferrin gene in an age-related manner [J].
Adrian, GS ;
Seto, E ;
Fischbach, KS ;
Rivera, EV ;
Adrian, EK ;
Herbert, DC ;
Walter, CA ;
Weaker, FJ ;
Bowman, BH .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 1996, 51 (01) :B66-B75
[8]  
AMMENDOLA R, 1992, J BIOL CHEM, V267, P17944
[9]  
[Anonymous], MOL CARCINOG
[10]  
[Anonymous], MOL CARCINOG